A Study to Determine the Effects of Multiple Doses of Mipomersen (200 mg SC) on the Pharmacodynamics and Pharmacokinetics of Single-dose Warfarin
Clinical trial NCT01133366 · COMPLETED
Trial details
- NCT number
- NCT01133366
- Sponsor
- Kastle Therapeutics, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2010-05-01
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.